Russell Investments Group, Ltd. Medicinova Inc Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$3.76 - $5.14 $124,760 - $170,550	-33,181 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$4.67 - $11.0 $154,955 - $364,991	33,181 New	33,181 $173,000
Q4 2017 Feb 06, 2018	SELL	$5.89 - $7.21 $97,567 - $119,433	-16,565 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$4.43 - $6.58 $73,382 - $108,997	16,565	16,565 $106,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $96.1M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.